Programme

  • Chair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King'’'s College London

    Whats emotionally unstable about early onset bipolar?
    Dr Aditya Sharma, Clinical Senior Lecturer and Hon Consultant in Child and Adolescent Psychiatry, Newcastle University

    Neurobiology and treatments for mania
    Dr Sameer Jauhar, Institute of Psychiatry, Psychology & Neuroscience, King's  College London

    Dissecting bipolar disorder using clinical and mobile assessments
    Professor Kathleen Ries Merikangas, Ph.D., Senior Investigator & Chief, Genetic & Epidemiology Research Unit
  • Chair: Professor Mike Crawford, Professor in Mental Health Research, Centre for Psychiatry, Imperial College, London

    ICD-11 Personality Disorders: A new way of conceptualising personality pathology
    Professor Peter Tyrer and Roger Mulder, Division of Clinical Psychiatry, Imperial College and Department of Psychological Medicine, University of Otago, Christchurch, New Zealand

    Implications of ICD-11 personality disorders in clinical practice: an eight-year clinical trial
    Dr Rahil Sanatinia, Research Associate, Centre for Psychiatry, Imperial College London
  • Chair: Dr Niall Boyce, Editor, The Lancet Psychiatry

    Scientific journals and social media: an unhappy marriage?
    Derek Tracy, The British Journal of Psychiatry

    Facilitating democratic conversations about mental health research welcome to the woodland!
    André Tomlin, The Mental Elf

    “Why on earth would you want to do that?”: One psychiatrist’s experience  of writing for the mainstream media
    Dr Mariam Alexander, West London NHS Trust

    What editors want, what readers want, and why it matters
    David Shariatmadari, Opinion Editor, The Guardian
  • Chair: Dr Catherine Hayhurst, Consultant in Emergency Medicine, Cambridge University Hospitals NHS Foundation Trust and Chair of Mental Health Subcommittee, Royal College of Emergency Medicine

    What’s the Evidence? An Overview of Research on Frequent Attendance
    Dr Alex Thomson, Consultant Liaison Psychiatrist, Central and North West London NHS Foundation Trust and Committee Member, RCPsych Liaison, Psychiatry Faculty Executive Committee

    What’s it Like? The Experience of Attending Emergency Departments Frequently with Mental Health Needs
    Dr Emma McAllister, Lived Experience Advisor, UK and Patient Representative, RCPsych Liaison Psychiatry Faculty Executive Committee

    What Helps? Top Tips for Achieving a Service with Impact
    Ms Rhian Monteith, Advanced Paramedic and Specialist Advisor, NHS RightCare

  • Speakers
    Professor David Baldwin, and Dr Samuel Chamberlain, University Department of Psychiatry, Faculty of Medicine, University of Southampton, United Kingdom

    We will describe the biological action of MAOIs and consider the evidence-base for their use in particular indications, incorporating available meta-analyses and clinical trial data. We will also consider safety issues including early and late adverse events; drug-drug interactions (including those likely to be overlooked such as informing patients about cold medications that can interact, and potential interactions with anesthetic agents); and dietary/food restrictions. This practical advice will include pointers to useful resources, including a dietary restrictions leaflet that can be discussed and shared with patients, and guidelines for treatment of depression and anxiety. 

  • Medical cannabis: The future is green
    Dr Chloe Sakal, Drug Science

    MDMA therapy for treating alcoholism
    Dr Ben Sessa, Imperial College London

    Psilocybin therapy for treating depression
    Dr Tim Williams, Clinical Director AWP
  • Chair: Prof John O’Brien, Department of Psychiatry, University of Cambridge

    Watch your step: Potential clinical applications of gait analysis in dementia
    Dr Ríona Mc Ardle, Newcastle University

    New insights from Epigenetics: DNA methylation alterations in Lewy Body Dementia
    Dr Leo Chouliaras, Department of Psychiatry, University of Cambridge

    Improving the diagnosis and management of Lewy body dementia: The DIAMOND-Lewy study
    Prof John O’Brien, Department of Psychiatry, University of Cambridge
  • Chair: Prof John O’Brien, Department of Psychiatry, University of Cambridge

    Can we prevent dementia?
    Prof Craig Ritchie, Centre for Clinical Brain Sciences, University of Edinburgh

    Can imaging detect changes 20 years before dementia onset?
    Prof John O’Brien, Department of Psychiatry, University of Cambridge

    Virtual reality as a putative tool for the early diagnosis of dementia
    Ms Coco Newton, Department of Psychiatry, University of Cambridge
  • Part 1

    Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and Neuroscience

    Cannabis and violence: is any association mediated by Paranoia?
    Sir Robin Murray, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience

    Treatment resistant psychosis in children and adolescents
     Dr Johnny Downs Institute of Psychiatry, Psychology and Neuroscience and Dr Marinos Kyriakopoulos, CAMHS, South London and Maudsley NHS Foundation Trust


    Part 2

    Chair: Dr Fiona Gaughran, Lead Consultant, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Reader, Institute of Psychiatry, Psychology and Neuroscience

    Genomics and Psychosis –when will the lab move into the clinic?
    Dr Mandy Johnstone National Psychosis Unit, South London and Maudsley NHS Foundation 

    Personalised Psychiatry for Psychosis; preliminary results from the MRCSTRATA Programme
    Professor James MacCabe, National Psychosis Unit, South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience

    A fine balance; quality and safe use of clozapine
    A/Prof Dan Siskind, Clinical Academic Psychiatrist, Metro South Addiction and Mental Health Service, Brisbane, Australia
  • Chair: Dr Ken Courtenay, Chair of the Faculty of Intellectual Disability, Royal College of Psychiatrists.

    Alzheimer’s Disease in Down Syndrome: a Genetic Condition with Variable Onset
    Prof. Andre Strydom, Professor of Intellectual Disabilities

    Genetic Testing in Clinical Practice: Towards a Cross-disciplinary Framework
    Dr Jana De Villiers, Consultant Psychiatrist in Intellectual Disability, Forensic Network Clinical Lead for Intellectual Disabilities

    Single Gene Disorders: Relevance to Patients, Families, and Clinicians
    Dr Lindsay Mizen, Consultant Psychiatrist West Lothian Community Learning Disability Team, Senior Clinical Research Fellow University of Edinburgh
  • Fighting The Friendly Foe. Personal Experience of Alcohol Addiction
    Diane Goslar, Expert by Experience

    Our Invisible Addicts” The changing face of alcohol and drug addiction
    Dr Tony Rao, Consultant Old Age Psychiatrists, South London and Maudsley NHS Foundation Trust

    Frightened, alone and away from home” Personal experience of drug addiction and co-morbid mental disorder
    Rachel Bannister, Expert by Experience
  • Chair: Professor Hamish McAllister-Williams, Newcastle University

    Assessment of sleep problems
    Dr Kirstie Anderson, Newcastle upon Tyne Hospitals NHS Foundation Trust

    Treatment of insomnia
    Dr Sue Wilson, Imperial College London

    Treatment of other sleep problems
    Dr Hugh Selsick, The Royal London Hospital for Integrated Medicine
  • Chair: Professor Allan Young, Institute of Psychiatry, Psychology and Neuroscience, King’s College London

    Next Generation Rapid Acting Antidepressants
    Carlos A. Zarate, Jr., M.D, National Institute of Mental Health

    An Update on Pharmacological Augmentation Strategies for Major Depressive Disorder
    Professor Anthony Cleare, Institute of Psychiatry, Psychology and Neuroscience, King’s College London

    Is transcranial direct current stimulation (tDCS) a treatment for depression?
    Professor Cynthia Fu, University of East London, Centre for Affective Disorders, IoPPN,
  • Chair: Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT

    Bipolar disorder and Postpartum Psychosis – can we individualise risk?
    Professor Ian Jones, Cardiff University

    Schizophrenia in women: what risk issues need to be considered in the perinatal period?
    Dr Liz McDonald, Clinical Lead for PMH Bursary Programme, RCPsych, Visiting Lecturer, Tavistock and Portman Trust, Hon. Consultant, ELFT

    Reducing risk of maternal suicide: lessons from the Confidential Enquiries into Maternal Deaths
    Dr Roch Cantwell, Consultant Perinatal Psychiatrist, Lead Clinician, Perinatal Mental Health Network Scotland
  • Chair: Prof Rupert McShane, Oxford Health NHS Foundation Trust and Dept Psychiatry, University of Oxford

    Ketamine to prevent Alcohol RElapse (KARE): an MRC funded study in Exeter and UCL
    Professor Celia Morgan, Professor of Psychopharmacology, Exeter University

    Open label extension data from an RCT of daily oral esketamine from Netherlands
    Jolien Veraart, Department of Psychiatry, University of Groningen, Netherlands

    Use of ketamine and related antidepressants in UK
    Prof Rupert McShane, Oxford Health NHS Foundation Trust and Dep Psychiatry, University of Oxford

  • This is a full day training course on Disorders at the Interface of Neurology and Psychiatry.

    Full details of speakers will be announced shortly.